| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2002-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8eb3ca946923deb700ec6a782fb064e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d98a927bf88d28d2de8cfdd455ac71b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a39a77d1971650ee512a1f7ccc131424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_508d341bcf81d5392b433dd3eac7b0f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b530179aa31d138cd28178ab585de85 |
| publicationDate |
2003-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003032619-A1 |
| titleOfInvention |
Pharmaceutical composition |
| abstract |
A liquid pharmaceutical composition providing improved oral bioavailability is disclosed for compounds which are inhibitors of HIV protease. In particular, the composition comprises a solution in a pharmaceutically acceptable organic solvent of (a) the HIV protease inhibitor and, optionally, (b) a surfactant. The composition can optionally be encapsulated in either hard gelatin capsules or soft elastic capsules (SEC). |
| priorityDate |
1996-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |